Bioventus (NASDAQ: BVS) net income
Bioventus reported a net profit of $22.7m for fiscal 2025; in fiscal 2024 it reported a net loss of $36.1m. Its net margin was 4.0%. Earnings per share were $0.34.
Fiscal 2025 is the highest of the 6 fiscal years on record for Bioventus. It reported a loss in 3 of those 6 years.
Embed this chart
Copy this code into your website or blog. The chart updates with each new annual report.
Net income by fiscal year
| Fiscal year | Net income | Change | Net margin | Earnings per share |
|---|---|---|---|---|
| 2025 | $22.7m | — | 4.0% | $0.34 |
| 2024 | −$36.1m | — | −6.3% | −$0.56 |
| 2023 | −$156.2m | — | −30.5% | −$2.49 |
| 2022 | −$158.7m | −919.1% | −31.0% | −$2.59 |
| 2021 | $19.4m | +18.1% | 4.5% | — |
| 2020 | $16.4m | — | 5.1% | — |
The change compares each fiscal year with the one before and is not calculated when the previous year closed with a loss. Net margin is net income over revenue from the same filing. Figures are in millions of US dollars, except per-share amounts.
Bioventus net income compared with its sector
By net income for its latest fiscal year, Bioventus ranks 145th of the 501 US health care companies with a page on Celsmar. The sector median net margin is −6.2%; that of Bioventus, 4.0%.
| Rank | Company | Net income | Net margin |
|---|---|---|---|
| 143rd | Siga Technologies | $23.3m | 24.6% |
| 144th | Privia Health Group | $22.9m | 1.1% |
| 145th | Bioventus | $22.7m | 4.0% |
| 146th | Astrana Health | $22.5m | 0.7% |
| 147th | Iradimed | $22.5m | 26.8% |
Each amount is in the currency the company reports in; the rank converts them to US dollars at the 16 November 2026 exchange rate. The rest are in US health care stocks.
Questions about the net income of Bioventus
- How much did Bioventus earn in fiscal 2025?
- Bioventus reported a net profit of $22.7m for fiscal 2025. In fiscal 2024 it reported a net loss of $36.1m.
- What are the earnings per share of Bioventus?
- They were $0.34 in fiscal 2025, compared with −$0.56 in fiscal 2024.
- What is the net margin of Bioventus?
- In fiscal 2025 its net profit was 4.0% of its revenue.
- What was the most profitable year for Bioventus?
- Of its last 6 fiscal years, fiscal 2025, with $22.7m.
- Where does Bioventus rank in its sector by net income?
- It ranks 145th of the 501 US health care companies with a page on Celsmar, by net income for its latest fiscal year.
- Where do the figures for Bioventus come from?
- From the annual report (Form 10-K) that Bioventus files with the SEC, the US securities regulator. Each fiscal year links to its filing.
Where each figure comes from
From the annual report (Form 10-K) that Bioventus files with the SEC. The filing for each fiscal year: 2025 · 2024 · 2023 · 2022 · 2021 · 2020. More on Bioventus: the Bioventus page · annual accounts · revenue · insider transactions.
Information prepared from the accounts the company files with the regulator, for information purposes only. It is not financial advice or a recommendation to buy or sell. Updated on 12 November 2026.